DEA schedule
Is Uptravi a controlled substance?
Uptravi contains selexipag. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Uptravi (selexipag) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and selexipag is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Uptravi?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 11 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | selexipag is not on the list |
Uptravi NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 66215-718 | UPTRAVI | injection, powder, for solution | 1800 ug/10mL | Actelion Pharmaceuticals US, Inc. | None |
| 66215-610 | UPTRAVI | tablet, coated | 1000 ug/1 | Actelion Pharmaceuticals US, Inc. | None |
| 66215-612 | UPTRAVI | tablet, coated | 1200 ug/1 | Actelion Pharmaceuticals US, Inc. | None |
| 66215-614 | UPTRAVI | tablet, coated | 1400 ug/1 | Actelion Pharmaceuticals US, Inc. | None |
| 66215-616 | UPTRAVI | tablet, coated | 1600 ug/1 | Actelion Pharmaceuticals US, Inc. | None |
| 66215-602 | UPTRAVI | tablet, coated | 200 ug/1 | Actelion Pharmaceuticals US, Inc. | None |
| 66215-604 | UPTRAVI | tablet, coated | 400 ug/1 | Actelion Pharmaceuticals US, Inc. | None |
| 66215-606 | UPTRAVI | tablet, coated | 600 ug/1 | Actelion Pharmaceuticals US, Inc. | None |
| 66215-608 | UPTRAVI | tablet, coated | 800 ug/1 | Actelion Pharmaceuticals US, Inc. | None |
| 66215-910 | UPTRAVI | tablet, film coated | 100 ug/1 | Actelion Pharmaceuticals US, Inc. | None |
| 66215-915 | UPTRAVI | tablet, film coated | 150 ug/1 | Actelion Pharmaceuticals US, Inc. | None |
Questions
Is Uptravi a controlled substance?
No. Uptravi (selexipag) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and selexipag is not on the DEA controlled substances list.
Is Uptravi a narcotic?
No. Uptravi (selexipag) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Prostacyclin Receptor Agonist.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.